Predictors and Impact of Timing of Disease Progression Following Primary Therapy in Multiple Myeloma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Predictors and Impact of Timing of Disease Progression Following Primary Therapy in Multiple Myeloma

Published:2023-11 Issue: Volume: Page:
ISSN:2152-2650
Container-title:Clinical Lymphoma Myeloma and Leukemia
language:en
Short-container-title:Clinical Lymphoma Myeloma and Leukemia

Author:

Goldman-Mazur Sarah,Visram Alissa,Rajkumar S. Vincent,Kapoor Prashant,Dispenzieri Angela,Lacy Martha Q.,Gertz Morie A.^ORCID,Buadi Francis K.,Hayman Suzanne R.,Dingli David,Kourelis Taxiarchis,Gonsalves Wilson,Warsame Rahma,Muchtar Eli^ORCID,Leung Nelson,Kyle Robert A.,Kumar Shaji K.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference29 articles.

1. Recent trends in multiple myeloma incidence and survival by age, race, and ethnicity in the United States;Costa;Blood Adv,2017

2. Early relapse after autologous transplant for myeloma is associated with poor survival regardless of cytogenetic risk;Corre;Haematologica,2020

3. Early relapse risk in patients with newly diagnosed multiple myeloma characterized by next-generation sequencing;Agostino;Clin Cancer Res,2020

4. Long PFS of more than 7 years is achieved in 9% of myeloma patients in the era of conventional chemotherapy and of first-generation novel anti-myeloma agents: a single-center experience over 20-year period;Terpos;Ann Hematol,2020

5. Frits van Rhee. Late relapsing multiple myeloma ≥ 10 years after treatment on total therapy protocols are associated with good outcome;Mohan,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP